JL

JFG Life Sciences Foundation

Description

JFG Life Sciences Foundation is a non-profit foundation.

Investor Profile

JFG Life Sciences Foundation has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Pre Seed, Seed rounds (top funding stages).
  • Majority of deals are located in Switzerland.
  • Strong thematic focus on Biotechnology, Life Science, Medical.

Stage Focus

  • Pre Seed (50%)
  • Seed (50%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Therapeutics
  • Biopharma
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JFG Life Sciences Foundation frequently co-invest with?

Venture Kick
Europe, Zurich, Switzerland, Schlieren
Co-Investments: 1
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
B
Europe, Basel-Landschaft, Switzerland, Allschwil
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
OCCIDENT
Europe, Bayern, Germany, Munich
Co-Investments: 1
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Wille Finance
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
K
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
AP
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1

What are some of recent deals done by JFG Life Sciences Foundation?

TECregen

Basel, Basel-Stadt, Switzerland

TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.

BiotechnologyManufacturingProduct Research
SeedJan 8, 2026
Amount Raised: $12,531,580
NXI Therapeutics

Basel, Basel-Stadt, Switzerland

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

BiotechnologyLife ScienceMedicalTherapeutics
Pre SeedJun 18, 2024
Amount Raised: $3,935,410
Invasight

Zürich, Zurich, Switzerland

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

BiopharmaBiotechnologyHealth Care
SeedJun 7, 2022
Amount Raised: $4,621,931

Find More Investors Like JFG Life Sciences Foundation

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

JFG Life Sciences Foundation | Pipeseed